Trial to assess safety, efficacy, tolerability and immunogenicity of influenza virus vaccine, administered concomitantly with a combination live, attenuated, mumps, measles, and rubella vaccine in healthy children aged 11-24 months

Trial Profile

Trial to assess safety, efficacy, tolerability and immunogenicity of influenza virus vaccine, administered concomitantly with a combination live, attenuated, mumps, measles, and rubella vaccine in healthy children aged 11-24 months

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2010

At a glance

  • Drugs Influenza virus vaccine live; Measles mumps and rubella virus vaccine
  • Indications Influenza virus infections; Measles; Mumps; Rubella
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Jan 2010 Results have been published in the journal Vaccine.
    • 01 Jan 2010 Primary endpoint 'Seroconversion rate' has not been met.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top